Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Angiodynamics (ANGO) EBIT Margin (2016 - 2025)

Historic EBIT Margin for Angiodynamics (ANGO) over the last 17 years, with Q4 2025 value amounting to 7.71%.

  • Angiodynamics' EBIT Margin rose 75200.0% to 7.71% in Q4 2025 from the same period last year, while for Nov 2025 it was 10.59%, marking a year-over-year increase of 726700.0%. This contributed to the annual value of 13.66% for FY2025, which is 496600.0% up from last year.
  • As of Q4 2025, Angiodynamics' EBIT Margin stood at 7.71%, which was up 75200.0% from 14.07% recorded in Q3 2025.
  • In the past 5 years, Angiodynamics' EBIT Margin registered a high of 44.52% during Q3 2023, and its lowest value of 265.88% during Q1 2024.
  • Moreover, its 5-year median value for EBIT Margin was 12.47% (2021), whereas its average is 23.25%.
  • Per our database at Business Quant, Angiodynamics' EBIT Margin tumbled by -2548200bps in 2024 and then surged by 2520300bps in 2025.
  • Over the past 5 years, Angiodynamics' EBIT Margin (Quarter) stood at 11.09% in 2021, then rose by 14bps to 9.5% in 2022, then crashed by -75bps to 16.59% in 2023, then increased by 8bps to 15.23% in 2024, then soared by 49bps to 7.71% in 2025.
  • Its EBIT Margin stands at 7.71% for Q4 2025, versus 14.07% for Q3 2025 and 7.22% for Q2 2025.